

| CFR | CFR | Patient | Symptoms | dip | dip | Pre | Post | Pre | Post | CFR | bas | bas | post | post | post | post | bas | dip | endo | endo | epi | bas | dip | dip | bas | dip | epi | endo | epi | endo | epi | bas |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Endo/ | Endo/ | Endo/ | Endo/ | endo | epi | epi | endo | pre | pre | post | post | Epi | Epi | Epi | Epi |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| 1.46 | 1.41 | 1.17 | 1.75 | 0.94 | 0.74 | 0.93 | 0.89 | 1.03 | 1.26 | 0.67 | 1.07 | 0.80 | 1.24 | 0.99 | 1.19 | A | l | 2 | 1.08 | 0.78 | 0.97 | 1.06 | 1.16 | A | 0.98 | 1.02 | 0.86 | 0.78 | 0.91 | 0.93 | 0.96 | 1.00 | 0.79 | 1.20 |  |
| 0.73 | 0.91 | 1.22 | 1.34 | 3 | B | 0.76 | 0.59 | 0.78 | 0.76 | 1.12 | 1.26 | 1.02 | 0.79 | 0.68 | 0.61 | 0.92 | 1.28 | 0.79 | 0.77 | 0.98 | 1.09 | 0.80 | 0.81 | 0.89 | 0.99 | 4 | — | - | - | - | - | - | - |  |  |
| ર | 0.82 | 1.32 | 1.56 | 0.79 | 0.80 | 1.42 | 2.16 | 1.67 | 0.84 | 0.66 | 0.97 | 1.91 | 1.80 | 2.70 | A | 1.36 | 0.99 | 1.87 | 1.33 | 6 | 0.93 | 0.87 | 1.24 | 1.56 | 1.40 | 1.62 | 1.18 | 1.07 | 1.34 | 0.81 | 1.38 | 1.79 | 0.86 | 0.84 | A |
| 7 | 1.25 | 1.00 | 1.59 | 1.56 | 1.24 | 0.94 | 1.23 | 1.26 | 0.64 | 0.78 | 0.75 | 1.27 | 0.60 | 0.99 | A | 1.33 | 1.07 | 1.22 | 1.11 | 2.16 | 2.38 | 8 | 0.47 | 0.56 | 0.51 | 1.04 | 1.04 | 1.21 | 1.09 | 1.09 | 1.00 | 1.86 | 2.03 | B | 0.56 |
| 0.75 | 9 | 0.90 | 0.90 | 1.47 | 0.76 | 1.41 | 1.42 | 0.62 | 1.63 | 1.89 | 1.87 | B | 0.90 | 1.01 | 0.98 | 1.00 | 1.00 | 2.33 | 3.02 | 0.63 | 1.57 | 1.92 | 1.14 | 1.01 | 1.27 | 1.18 | 1.13 | 0.82 | 1.09 | 1.11 | 1.16 | 10 | B | 0.67 | 1.06 |
| 1.18 | 1.25 | 1.21 | 1.42 | 1.22 | 1.18 | 1.19 | 1.06 | 1.43 | 1.14 | 1.22 | 1.46 | 1.74 | 1.62 | 1.04 | 0.85 | 11 | A | 1.15 | 0.70 | 1.22 | 2.03 | 1.12 | 0.94 | 1.21 | 0.88 | 1.78 | 1.20 | 1.20 | 1.26 | 1.05 | 1.51 | 1.07 | 1.71 | 12 | B |
| 0.74 | 1.08 | 0.93 | 1.05 | 0.93 | 1.08 | 0.83 | 1.17 | 1.13 | 1.15 | 1.30 | 1.25 | 1.26 | 1.03 | 0.89 | 13 | 0.86 | A | 1.14 | 1.93 | 1.39 | 1.59 | 1.00 | 1.25 | 1.19 | 1.17 | 1.43 | 1.22 | 0.78 | 1.05 | 14 | 1.35 | 1.05 | 1.59 | 1.39 | A |
| 1.19 | 1.37 | 1.71 | 15 | 0.69 | 0.69 | 0.95 | 0.85 | 0.55 | 0.83 | 1.05 | 1.00 | 1.56 | 0.80 | 0.80 | 0.97 | 1.92 | B |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| 0.90 | 1.16 | 1.30 | 1.05 | 1.20 | 1.19 | 1.13 | 1.18 | 0.93 | 1.06 | 1.24 | 1.54 | 1.24 | 1.00 | 0.89 | 1.43 | Mean | 0.26 | 0.32 | 0.34 | 0.38 | 0.29 | 0.36 | 0.21 | 0.24 | 0.46 | 0.56 | 0.47 | SD | 0.29 | 0.35 | 0.18 | 0.24 | 0.54 |  |  |

Table 3 Myocardial blood flow in subepicardial and subendocardial septum

Key: Symptoms = change in symptomatic status after verapamil; A = improved (n = 8); B = worsened or no change (n = 6); dip = dipyridamole; bas = baseline; endo = subendocardial; epi = subepicardial; Endo/Epi = subendocardial/subepicardial flow ratio; pre/post = pre and post verapamil therapy respectively; CFR = coronary flow reserve (dipyridamole/baseline myocardial blood flow). All values of myocardial blood flow are in ml/ming

Fig. 3 Values of myocardial blood flow (MBF) are shown for subendocardial (endo) and subepicardial (epi) septal regions before and after treatment in patients that improved symptomatically following drug therapy (group A) and in those that reported no change or a worsening of symptoms (group B). All values represent mean + 1 standard deviation.

![](_page_0_Figure_5.jpeg)

